DocCheck AG is a Germany-based Company. The Company is engaged in the healthcare sector. The are three main business areas: agency business, access business and retail business. The agency business develops and implements communication concepts for the healthcare and B2B market. The access business helps to grow community for medical professionals. It also includes online advertising, online market research, online studies. The retail business provides medical supplies and medical technology.

Employees

414

Sector

Healthcare Facilities & Services

More about the company

Quotes

Date	Price	Change
18/09/26	€11.00	0.00%
17/09/26	€11.00	0.00%
16/09/26	€11.00	+0.92%
15/09/26	€10.90	0.00%
14/09/26	€10.90	0.00%

Delayed Quote Deutsche Boerse AG

More quotes

Market Closed - Deutsche Boerse AG 14:25:02 18/09/2026 BST			5-day change	1st Jan Change
11.00 ^EUR	0.00%		+0.92%	-9.84%

04-16	DocCheck AG announces Annual dividend, payable on June 02, 2026	CI
04-08	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Market Cap	56.32M 64.59M 53.18M 48.29M 90.48M 6.2B 90.85M 637M 246M 3.15B 243M 237M 10.14B	P/E 2024	8.03x	P/E 2025	11.7x
Enterprise Value	38.73M 44.41M 36.57M 33.21M 62.22M 4.26B 62.48M 438M 169M 2.17B 167M 163M 6.97B	EV / Sales 2024	0.41x	EV / Sales 2025	0.81x
Free-Float	28.08%	Yield 2024	8.98%	Yield 2025	8.13%

Markets		Quality
Xetra	AJ91	Delayed
Tradegate	AJ91	Real-time
Boerse Muenchen	AJ91	Real-time
Deutsche Boerse AG	AJ91	Delayed
Börse Stuttgart	AJ91	Delayed

04-16	DocCheck AG announces Annual dividend, payable on June 02, 2026	CI
04-08	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2025	CI
29/09/25	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2025	CI
15/04/25	DocCheck AG announces Annual dividend, payable on June 02, 2025	CI
09/04/25	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2024	CI
23/09/24	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2024	CI
11/04/24	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2023	CI
30/09/23	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2023	CI
13/04/23	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2022	CI
29/07/22	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2022	CI
14/04/22	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2021	CI
28/10/21	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2021	CI
15/04/21	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2020	CI

DocCheck AG Share Price Deutsche Boerse AG

Stocks

AJ91

DE000A1A6WE6

Healthcare Facilities & Services

Valuation: DocCheck AG

Chart: DocCheck AG

Latest news: DocCheck AG

Press Releases: DocCheck AG

News in other languages: DocCheck AG

Quotes and Performance

Price Extremes

Managers and Directors: DocCheck AG

Other Healthcare Facilities & Services

Financials

Company Profile

Quotes

04-16	DocCheck : Information pursuant to Section 125 para. 2 German Stock Corporation Act (AktG) in connection with Section 125 para. 5 AktG, Article 4 para. 1 and Table 3 of the Annex to Implementing Regulation (EU) 2018/1212 (DocCheck Informationen nach 125 AktG und Tabelle 3 Blocke A bis F Durchfuhrungsverordnung EU 2018 1212 engl)	PU
15/04/25	DocCheck : Information pursuant to Section 125 para. 2 German Stock Corporation Act (AktG) in connection with Section 125 para. 5 AktG, Article 4 para. 1 and Table 3 of the Annex to Implementing Regulation (EU) 2018/1212 (2025 DocCheck Informationen nach 125 AktG englisch und Tabelle 3 Bloecke A to F)	PU
04/05/23	DD: DocCheck AG: Dr. Frank Antwerpes, buy	EQ
05/03/20	DocCheck AG : Notification and public disclosure of transactions by persons	EQ

08-05	DocCheck Gruppe: Vorläufige Zahlen zum ersten Halbjahr 2026
05-28	DocCheck : Abstimmungsergebnisse (AJ91 Abstimmungsergebnisse HV2026)
05-28	DocCheck : Nachtrag (AJ91 1 Nachtrag)
05-25	Kalender der Dividendenausschüttungen und Hauptversammlungen vom 25. bis 29. Mai 2026
05-20	Vorläufige Zahlen zum ersten Quartal 2026

1 week	+0.92%
1 month	+3.77%
3 months	-6.78%
6 months	-8.33%
Current year	-9.84%

1 week	10.8	11.2
1 month	10.7	11.5
Current year	10.6	15.3
1 year	10.6	15.3
3 years	7	15.3
5 years	7	35.1
10 years	6.72	35.1

Manager	Title	Age	Since
Frank Nicolas Antwerpes CEO	Chief Executive Officer	65	-
Philip Stadtmann DFI	Director of Finance/CFO	-	31/07/2019
Jens Knoop CTO	Chief Tech/Sci/R&D Officer	-	31/07/2019

Director	Title	Age	Since
Joachim Pietzko CHM	Chairman	-	14/12/2014
Winfried Leimeister BRD	Director/Board Member	-	31/12/1998
Karin Immenroth BRD	Director/Board Member	-	30/03/2022

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
DOCCHECK AG	0.00%	+0.92%	-	-	64.59M
CVS HEALTH CORPORATION	-1.58%	-6.15%	+19.38%	+25.66%	114B
HCA HEALTHCARE, INC.	-0.31%	+0.18%	+6.64%	+67.26%	92.6B
FRESENIUS SE & CO. KGAA	-0.05%	+2.39%	-1.92%	+53.10%	29.66B
QUEST DIAGNOSTICS INCORPORATED	-0.40%	+4.86%	+34.43%	+95.92%	27.2B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	-1.13%	-2.02%	-9.74%	-3.96%	21.24B
TENET HEALTHCARE CORPORATION	+0.03%	-0.64%	+37.68%	+274.16%	21.1B
REDE D'OR SÃO LUIZ S.A.	+0.27%	-1.01%	-9.92%	+31.23%	15.71B
FRESENIUS MEDICAL CARE AG	-0.79%	+0.65%	-10.32%	-8.19%	11.76B
DAVITA INC.	+0.42%	+1.27%	+41.18%	+84.28%	11.73B
Average	-0.35%	-0.05%	+11.93%	+68.83%	38.29B
Weighted average by Cap.	-0.71%	-1.53%	+13.03%	+59.23%

	2024	2025
Net sales	53.79M 61.68M 50.79M 46.12M 86.41M 5.92B 86.77M 608M 235M 3.01B 232M 227M 9.68B	55.32M 63.44M 52.23M 47.43M 88.86M 6.09B 89.23M 626M 241M 3.09B 238M 233M 9.96B
Net income	5.28M 6.06M 4.99M 4.53M 8.49M 581M 8.52M 59.76M 23.06M 296M 22.76M 22.25M 951M	5.33M 6.12M 5.04M 4.57M 8.57M 587M 8.61M 60.33M 23.28M 298M 22.98M 22.47M 960M
Net Debt	-20.11M -23.06M -18.99M -17.24M -32.3M -2.21B -32.44M -227M -87.76M -1.12B -86.62M -84.7M -3.62B	-17.59M -20.17M -16.61M -15.08M -28.26M -1.94B -28.38M -199M -76.77M -984M -75.77M -74.09M -3.17B